Clinicians, health-system executives, technologists, investors and policy leaders are gathering at the Yale Club of New York from 9 to 11 October for the Global Health Congress 2026, a three-day meeting built around a single organising idea: that the next breakthroughs in health will come from connections between disciplines rather than from within any one of them.
The format is deliberately senior and deliberately commercial-free in one respect — there is no traditional expo hall or pay-to-play booth model. More than eighty speakers across twenty topics, including hospital chief executives, chief medical officers, chief AI and digital officers, health-plan leaders, medical-school deans and investors, are scheduled alongside a venture forum at which twelve healthcare founders pitch to investors and strategic partners. The founder of the congress frames the design plainly: the people who run hospitals, fund innovation and shape policy rarely sit at one table, and the meeting exists to make them leave with partnerships rather than business cards.
The agenda’s centre of gravity — artificial intelligence in care delivery, system finances, workforce and access — mirrors where health leadership anxiety actually lives in 2026. Every system in the room is being asked to deploy AI faster than its governance was designed for, to treat more patients with staff it cannot hire, and to pay for medicines and technologies whose benefits arrive over years against budgets set annually. A congress cannot solve those equations, but the attendee list determines whether its conversations are theoretical or operational, and this one is weighted toward operators.
Scepticism is the correct companion. Convenings of this kind produce memoranda of understanding at a higher rate than changed patient outcomes, and venture forums measure success in term sheets rather than in treated illness. The test of this week’s meeting will be visible in twelve months: partnerships announced with dates attached, pilots that reached patients, and collaborations that survived contact with procurement.
For morning readers, the signal is the consensus on display. When the people who run, fund and regulate care all describe the silo as the disease, the industry’s next reorganisations — merged data, shared AI infrastructure, cross-discipline teams — stop being conference language and become budgets. Watch what the attendees announce together on their return; that, not the keynote, is the news.
